Stephen Huynh, DO
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huynh’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$89,614
Medicare paid this office $89,614 for 336 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 194 | $41,121 | $109 |
| Short return visit (20+ min) | 123 | $13,538 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 80 | $12,436 | $155 |
| New patient visit (45+ min) | 66 | $7,812 | $118 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,080 | $291 |
See all 10 services
| Return visit (30+ min) | 194 | $41,121 | $109 |
| Short return visit (20+ min) | 123 | $13,538 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 80 | $12,436 | $155 |
| New patient visit (45+ min) | 66 | $7,812 | $118 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,080 | $291 |
| New patient visit (30+ min) | 32 | $2,325 | $73 |
| Influenza vaccine split virus, preservative free | 27 | $2,199 | $81 |
| Administration of influenza virus vaccine | 27 | $1,055 | $39 |
| Administration of pneumococcal vaccine | 14 | $547 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 22 | $374 | $15 |
Who their Medicare patients are
336 Original Medicare patients in 2024. Average age 74 · Under 65 3% · 85 and older 11% · Women 49% · Also on Medicaid 7% · Health risk score 0.99. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 28% · Coronary heart disease 24% · Chronic kidney disease 21% · Cancer 18% · Atrial fibrillation 16% · Depression 14% · Heart failure 11% · COPD 11% · Stroke 7% · Dementia 6%.
The office billed $364,530, Medicare allowed $120,017 and paid $89,614; for 874 services of 28 kinds; $6,284 of it was for drugs given in the office and $83,330 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 336 | 874 | 74 | 0.99 | $364,530 | $89,614 |
| 2023 | 414 | 970 | 74 | 1.01 | $315,932 | $86,842 |
| 2022 | 451 | 1,088 | 74 | 0.97 | $308,762 | $91,777 |
| 2021 | 272 | 566 | 74 | 0.86 | $132,733 | $38,549 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 179 | $28,763 | $99 |
| Short return visit (20+ min) | 228 | $20,495 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 93 | $14,499 | $156 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 24 | $6,751 | $281 |
| New patient visit (45+ min) | 28 | $3,565 | $127 |
| Influenza vaccine split virus, preservative free | 32 | $2,292 | $72 |
| Administration of influenza virus vaccine | 34 | $1,257 | $37 |
| Administration of pneumococcal vaccine | 34 | $1,257 | $37 |
| Adm sarscv2 bvl 30mcg/.3ml a | 21 | $1,035 | $49 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $771 | $51 |
| New patient visit (30+ min) | 11 | $749 | $68 |
| Removal of impacted ear wax by washing | 11 | $220 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $156 | $12 |
2022: 9 services
| Return visit (30+ min) | 174 | $30,001 | $103 |
| Short return visit (20+ min) | 190 | $18,963 | $76 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $13,167 | $159 |
| Influenza vaccine split virus, preservative free | 117 | $8,009 | $68 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 20 | $5,572 | $279 |
| Administration of influenza virus vaccine | 123 | $4,620 | $37 |
| New patient visit (45+ min) | 30 | $3,223 | $107 |
| Pneumococcal vaccine, 23-valent | 11 | $1,462 | $133 |
| Administration of pneumococcal vaccine | 31 | $1,162 | $37 |
2021: 6 services
| Short return visit (20+ min) | 108 | $10,940 | $84 |
| Influenza vaccine split virus, preservative free | 124 | $8,092 | $65 |
| Return visit (30+ min) | 48 | $7,126 | $125 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,708 | $161 |
| Administration of influenza virus vaccine | 133 | $2,874 | $22 |
| New patient visit (45+ min) | 15 | $2,213 | $148 |
Drugs they prescribed that Part D paid
$155,554
Pharmacies billed $155,554 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,333 generic and fewer than 11 brand-name prescriptions · $155,554 in drug cost · 66 antibiotic prescriptions to 55 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 31 | $38,717 | $1,249 |
| Eliquis | 32 | $23,665 | $740 |
| Ozempic | 13 | $19,942 | $1,534 |
| Atorvastatin | 216 | $1,875 | $9 |
| Rosuvastatin | 125 | $1,504 | $12 |
See all 54 drugs
| Jardiance | 31 | $38,717 | $1,249 |
| Eliquis | 32 | $23,665 | $740 |
| Ozempic | 13 | $19,942 | $1,534 |
| Atorvastatin | 216 | $1,875 | $9 |
| Rosuvastatin | 125 | $1,504 | $12 |
| Synthroid | 17 | $1,203 | $71 |
| Amlodipine Besylate | 209 | $1,169 | $6 |
| Albuterol Sulfate Hfa | 20 | $1,108 | $55 |
| Metoprolol | 53 | $1,078 | $20 |
| Tamsulosin | 59 | $1,045 | $18 |
| Losartan | 100 | $894 | $9 |
| Levothyroxine | 103 | $760 | $7 |
| Gabapentin | 44 | $664 | $15 |
| Irbesartan | 11 | $656 | $60 |
| Lisinopril | 109 | $644 | $6 |
| Metformin Hcl Er | 55 | $575 | $10 |
| Pravastatin | 44 | $534 | $12 |
| Escitalopram | 26 | $506 | $19 |
| Omeprazole | 35 | $481 | $14 |
| Valsartan | 21 | $474 | $23 |
| Diclofenac | 29 | $446 | $15 |
| Pantoprazole | 27 | $440 | $16 |
| Potassium Chloride | 19 | $405 | $21 |
| Metformin | 49 | $358 | $7 |
| Sertraline | 39 | $324 | $8 |
| Trazodone | 24 | $310 | $13 |
| Carvedilol | 25 | $297 | $12 |
| Alendronate | 41 | $288 | $7 |
| Finasteride | 17 | $278 | $16 |
| Losartan-Hydrochlorothiazide | 13 | $258 | $20 |
| Allopurinol | 36 | $256 | $7 |
| Testosterone | 12 | $237 | $20 |
| Hydrochlorothiazide | 67 | $229 | $3 |
| Mirtazapine | 22 | $203 | $9 |
| Lovastatin | 20 | $202 | $10 |
| Spironolactone | 20 | $195 | $10 |
| Simvastatin | 32 | $180 | $6 |
| Venlafaxine Hcl Er | 13 | $163 | $13 |
| Montelukast | 15 | $162 | $11 |
| Metoprolol | 19 | $143 | $8 |
| Nitrofurantoin Mono-Macro | 14 | $143 | $10 |
| Famotidine | 13 | $131 | $10 |
| Benazepril | 18 | $108 | $6 |
| Zolpidem | 26 | $95 | $4 |
| Atenolol | 20 | $82 | $4 |
| Azithromycin | 32 | $67 | $2 |
| Citalopram Hbr | 13 | $66 | $5 |
| Furosemide | 25 | $64 | $3 |
| Cyclobenzaprine | 13 | $60 | $5 |
| Warfarin | 12 | $55 | $5 |
| Triamcinolone Acetonide | 16 | $52 | $3 |
| Glimepiride | 11 | $44 | $4 |
| Lorazepam | 12 | $39 | $3 |
| Paxlovid | 17 | $0 | $0 |
Year by year
| 2024 | 2,565 | 558 | None | None | $155,554 |
| 2023 | 3,408 | 472 | 4% (143) | 6% | $193,098 |
| 2022 | 3,374 | 514 | 6% (194) | 6% | $188,749 |
| 2021 | 717 | 281 | 7% (48) | None | $40,321 |
| 2020 | 353 | 147 | 0% (0) | None | $23,352 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 66 drugs
| Jardiance | None | 23 | $40,004 | $1,739 |
| Eliquis | None | 20 | $25,592 | $1,280 |
| Aimovig | Migraine | 11 | $7,886 | $717 |
| Atorvastatin | None | 324 | $4,303 | $13 |
| Rosuvastatin | None | 76 | $2,311 | $30 |
| Amlodipine Besylate | None | 173 | $2,134 | $12 |
| Tamsulosin | None | 93 | $2,039 | $22 |
| Losartan | None | 117 | $1,961 | $17 |
| Hydrocodone-Acetaminophen | None | 94 | $1,870 | $20 |
| Lisinopril | None | 179 | $1,706 | $10 |
| Pravastatin | None | 64 | $1,697 | $27 |
| Metoprolol | None | 67 | $1,680 | $25 |
| Albuterol Sulfate Hfa | None | 31 | $1,454 | $47 |
| Synthroid | None | 11 | $1,380 | $125 |
| Levothyroxine | None | 93 | $1,367 | $15 |
| Metformin | None | 74 | $1,195 | $16 |
| Duloxetine | None | 25 | $1,118 | $45 |
| Metformin Hcl Er | None | 78 | $1,088 | $14 |
| Nano 2nd Gen Pen Needle | None | 14 | $1,037 | $74 |
| Gabapentin | None | 52 | $949 | $18 |
| Allopurinol | None | 60 | $810 | $14 |
| Losartan-Hydrochlorothiazide | None | 27 | $807 | $30 |
| Irbesartan | None | 11 | $724 | $66 |
| Simvastatin | None | 71 | $708 | $10 |
| Escitalopram | None | 29 | $656 | $23 |
| Lisinopril-Hydrochlorothiazide | None | 44 | $652 | $15 |
| Bupropion Xl | None | 18 | $544 | $30 |
| Pregabalin | None | 29 | $511 | $18 |
| Finasteride | None | 28 | $481 | $17 |
| Montelukast | None | 29 | $463 | $16 |
| Atenolol | None | 34 | $437 | $13 |
| Pantoprazole | None | 24 | $413 | $17 |
| Fluoxetine | None | 24 | $402 | $17 |
| Alprazolam | None | 47 | $396 | $8 |
| Zolpidem | None | 58 | $357 | $6 |
| Sertraline | None | 30 | $357 | $12 |
| Alendronate | None | 32 | $352 | $11 |
| Trazodone | None | 38 | $345 | $9 |
| Oxycodone | None | 15 | $343 | $23 |
| Mirtazapine | None | 22 | $303 | $14 |
| Hydrochlorothiazide | None | 75 | $301 | $4 |
| Omeprazole | None | 31 | $274 | $9 |
| Paroxetine | None | 12 | $273 | $23 |
| Estradiol-Norethindrone Acetat | None | 13 | $266 | $20 |
| Carvedilol | None | 17 | $254 | $15 |
| Diclofenac | None | 18 | $249 | $14 |
| Fluticasone Propionate | None | 14 | $193 | $14 |
| Lorazepam | None | 26 | $188 | $7 |
| Glipizide Er | None | 11 | $182 | $17 |
| Spironolactone | None | 17 | $181 | $11 |
| Famotidine | None | 18 | $179 | $10 |
| Lovastatin | None | 23 | $178 | $8 |
| Pramipexole Dihydrochloride | None | 14 | $170 | $12 |
| Citalopram Hbr | None | 20 | $170 | $8 |
| Triamcinolone Acetonide | None | 19 | $160 | $8 |
| Metoprolol | None | 14 | $151 | $11 |
| Glimepiride | None | 17 | $146 | $9 |
| Diazepam | None | 20 | $142 | $7 |
| Paxlovid (Eua) | None | 13 | $136 | $10 |
| Ibuprofen | None | 13 | $133 | $10 |
| Benazepril | None | 14 | $133 | $10 |
| Warfarin | None | 21 | $131 | $6 |
| Azithromycin | None | 13 | $115 | $9 |
| Meloxicam | None | 13 | $110 | $8 |
| Furosemide | None | 23 | $94 | $4 |
| Glipizide | None | 11 | $63 | $6 |
2022: 73 drugs
| Jardiance | 15 | $24,681 | $1,645 |
| Eliquis | 20 | $17,616 | $881 |
| Atorvastatin | 257 | $2,639 | $10 |
| Hydrocodone-Acetaminophen | 111 | $2,353 | $21 |
| Rosuvastatin | 48 | $1,583 | $33 |
| Metoprolol | 70 | $1,534 | $22 |
| Lisinopril | 147 | $1,400 | $10 |
| Losartan | 93 | $1,327 | $14 |
| Pregabalin | 37 | $1,272 | $34 |
| Amlodipine Besylate | 149 | $1,256 | $8 |
| Oxycodone-Acetaminophen | 21 | $1,198 | $57 |
| Levothyroxine | 80 | $1,175 | $15 |
| Albuterol Sulfate Hfa | 22 | $1,162 | $53 |
| Pravastatin | 49 | $1,112 | $23 |
| Alprazolam | 86 | $963 | $11 |
| Tamsulosin | 62 | $918 | $15 |
| Quetiapine | 23 | $826 | $36 |
| Tramadol Hcl Er | 11 | $722 | $66 |
| Pantoprazole | 37 | $632 | $17 |
| Metformin Hcl Er | 76 | $598 | $8 |
| Allopurinol | 56 | $595 | $11 |
| Simvastatin | 70 | $588 | $8 |
| Gabapentin | 58 | $584 | $10 |
| Losartan-Hydrochlorothiazide | 18 | $554 | $31 |
| Trazodone | 58 | $529 | $9 |
| Escitalopram | 36 | $483 | $13 |
| Oxybutynin Chloride Er | 14 | $459 | $33 |
| Sertraline | 31 | $450 | $15 |
| Montelukast | 22 | $418 | $19 |
| Zolpidem | 69 | $417 | $6 |
| Clopidogrel | 21 | $411 | $20 |
| Atenolol | 42 | $406 | $10 |
| Cyclobenzaprine | 34 | $386 | $11 |
| Diclofenac | 21 | $364 | $17 |
| Irbesartan | 14 | $354 | $25 |
| Famotidine | 20 | $350 | $17 |
| Fluoxetine | 31 | $324 | $10 |
| Omeprazole | 26 | $301 | $12 |
| Fluticasone Propionate | 23 | $299 | $13 |
| Oxycodone | 13 | $298 | $23 |
| Hydrochlorothiazide | 88 | $296 | $3 |
| Metformin | 54 | $295 | $5 |
| Spironolactone | 16 | $294 | $18 |
| Lisinopril-Hydrochlorothiazide | 24 | $286 | $12 |
| Glimepiride | 12 | $276 | $23 |
| Paroxetine | 11 | $276 | $25 |
| Lorazepam | 41 | $249 | $6 |
| Finasteride | 17 | $248 | $15 |
| Buspirone | 12 | $244 | $20 |
| Nystatin | 12 | $234 | $20 |
| Tramadol | 24 | $184 | $8 |
| Carvedilol | 16 | $169 | $11 |
| Glipizide | 13 | $161 | $12 |
| Alendronate | 17 | $158 | $9 |
| Nitrofurantoin Mono-Macro | 17 | $139 | $8 |
| Paxlovid (Eua) | 15 | $136 | $9 |
| Lovastatin | 18 | $135 | $8 |
| Carisoprodol | 13 | $124 | $10 |
| Citalopram Hbr | 16 | $115 | $7 |
| Diazepam | 21 | $109 | $5 |
| Furosemide | 28 | $107 | $4 |
| Ondansetron Odt | 13 | $96 | $7 |
| Metoprolol | 15 | $94 | $6 |
| Meloxicam | 20 | $90 | $4 |
| Azithromycin | 18 | $86 | $5 |
| Ibuprofen | 14 | $85 | $6 |
| Nabumetone | 12 | $81 | $7 |
| Benazepril | 11 | $75 | $7 |
| Triamcinolone Acetonide | 15 | $69 | $5 |
| Naproxen | 15 | $56 | $4 |
| Enalapril Maleate | 11 | $40 | $4 |
| Prednisone | 11 | $38 | $3 |
| Sildenafil Citrate | 12 | $32 | $3 |
2021: 14 drugs
| Hydrocodone-Acetaminophen | 28 | $655 | $23 |
| Atorvastatin | 43 | $513 | $12 |
| Gabapentin | 23 | $349 | $15 |
| Lisinopril | 36 | $346 | $10 |
| Levothyroxine | 23 | $324 | $14 |
| Alprazolam | 20 | $253 | $13 |
| Atenolol | 13 | $195 | $15 |
| Amlodipine Besylate | 41 | $176 | $4 |
| Simvastatin | 18 | $114 | $6 |
| Famotidine | 14 | $111 | $8 |
| Hydrochlorothiazide | 15 | $100 | $7 |
| Trazodone | 14 | $95 | $7 |
| Zolpidem | 14 | $73 | $5 |
| Chlorthalidone | 11 | $72 | $7 |
2020: 7 drugs
| Atorvastatin | 31 | $384 | $12 |
| Levothyroxine | 15 | $263 | $18 |
| Amlodipine Besylate | 27 | $125 | $5 |
| Losartan | 12 | $100 | $8 |
| Metformin | 12 | $95 | $8 |
| Lisinopril | 14 | $82 | $6 |
| Hydrochlorothiazide | 11 | $63 | $6 |
Money from drug and device companies
$23 in 2025
| 2025 | 1 | 1 | None | $23 |
| 2022 | 1 | 1 | None | $17 |
| 2021 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Advate | $23 | 1 payment
|
See the published payment
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-24 | Advate | $23 |
See earlier years (2022, 2021)
2022: $17
| Pfizer | Prevnar 20 | $17 | 1 payment
|
2021: $24
| Alkermes | Aristada | $24 | 1 payment
|
Professional record
- NPI
- 1093206633
- Licence
- CA 20A17815
- Trained
- Touro Un College of Osteopathic Medicine, Vallejo, 2018
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032
- NPI first listed
- 2018-05-18
- NPI last updated
- 2021-06-11
- NPI record certified
- 2021-06-11
This is when the NPI record was last certified, not a medical board exam.